MediWound Ltd
NASDAQ:MDWD 10:20:20 AM EDT
| Market Cap (Intraday) | 207.67M |
| Current PE | N/A |
| Forward PE | N/A |
| 2yr Forward PE | N/A |
| 10-Day MA | $19.54 |
| 50-Day MA | $19.60 |
| 200-Day MA | $17.97 |
MediWound Ltd Stock, NASDAQ:MDWD
42 Hayarkon Street, 42 Hayarkon Street, Yavne, HaMerkaz 8122745
Israel
Phone: +972.77.971.4100
Number of Employees: 111
Description
MediWound Ltd. is a biopharmaceutical company, which engages in the development, manufacture, and commercialization of products to address needs in the fields of severe burns, chronic wounds, and other hard-to-heal wounds. Its product NexoBrid, is an orphan biologic for eschar removal in severe burns. The company was founded by Lior Rosenberg and Marian Gorecki in January 2000 and is headquartered in Yavne, Israel.